Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Exosome preparation deriving from human umbilical cord mesenchymal stem cells

A technology of mesenchymal stem cells and human umbilical cord, applied in the direction of cell culture active agents, animal cells, vertebrate cells, etc., can solve the problems of cumbersome process and large cost

Pending Publication Date: 2020-10-27
深圳国科靶点药物有限公司
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the large size of human umbilical cord mesenchymal stem cells, there is a blood-gas barrier barrier in human application, and the number that can reach the action site is small, and maintaining cell activity during storage and transportation requires cumbersome processes and a lot of cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Exosome preparation deriving from human umbilical cord mesenchymal stem cells
  • Exosome preparation deriving from human umbilical cord mesenchymal stem cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0029] An exosome preparation derived from human umbilical cord mesenchymal stem cells, including the following raw materials: Lonza UltraCULTURE serum-free medium, 0.9% sodium chloride injection, 75% alcohol, PALL UltroserG serum substitute, L-Glutamine, Ganoderma lucidum polysaccharide, Gibco 0.05% Trypsin-EDTA.

[0030] (2) A preparation method for exosome preparation derived from human umbilical cord mesenchymal stem cells, comprising the following steps: (1) resuspending ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an exosome preparation deriving from human umbilical cord mesenchymal stem cells. The exosome preparation contains the following raw materials: a Lonza UltraCULTURE serum-freemedium, a PALL UltroserG serum substitute, L-Glutamine and ganoderan. The exosome preparation is prepared by the following steps: dissociating cultured cells, washing the cells by virtue of a sodium chloride injection, and adding the cells into culture supernatant; putting culture supernatant into an ultra-low-temperature refrigerator for refrigeration; taking out the culture supernatant for unfreezing, carrying out high-speed centrifugation, concentrating the supernatant by virtue of an ultrafiltration membrane, and adding sodium hyaluronate, human serum albumin and trehalose, so as to prepare the exosome preparation deriving from the human umbilical cord mesenchymal stem cells. By utilizing a serum-free culture system in a preparation method of the exosome preparation deriving from the human umbilical cord mesenchymal stem cells, the quality is stable, the batch difference is small, and an exogenous pathogenic factor is not introduced; by adding the ganoderan, proliferation of the umbilical cord mesenchymal stem cells can be promoted, and secretion of exosomes by the umbilical cord mesenchymal stem cells can be promoted; a complete culture medium and a condition culture medium are used for acquiring the exosomes, so that the yield is increased; and after the cells are frozen and dissociated, contents are mixed into the culture supernatant, so that the concentration of activesubstances is increased, and the exosome preparation is a face-beautifying anti-aging biological preparation with an excellent effect.

Description

technical field [0001] The invention relates to the technical field of mesenchymal stem cells, in particular to a method for preparing an exosome preparation derived from human umbilical cord mesenchymal stem cells. Background technique [0002] Mesenchymal stem cells are a kind of pluripotent stem cells, which have all the common characteristics of stem cells, that is, self-renewal and multidirectional differentiation capabilities. Major breakthroughs have been made in vascular diseases, liver cirrhosis, nervous system diseases, partial knee meniscectomy injury repair, autoimmune diseases, etc., saving the lives of more patients. Due to the large size of human umbilical cord mesenchymal stem cells, there is a blood-air barrier barrier in human application, and the number that can reach the action site is small, and maintaining cell activity during storage and transportation requires cumbersome processes and a lot of cost. Exosomes are subcellular double-layer membrane vesi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0775
CPCC12N5/0665C12N2500/34C12N2501/998C12N2509/00
Inventor 刘瑾卢明星刘福京
Owner 深圳国科靶点药物有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products